Single-Center Intelligent Pulmonary Rehabilitation After Lung Cancer Surgery
A Randomized Controlled Trial of an Intelligent Pulmonary Function Exercise Device Versus Usual Care for In-Hospital and Home-Based Pulmonary Rehabilitation After Lung Cancer Surgery
This study will compare an intelligent pulmonary function exercise device with usual care and natural recovery in patients recovering from lung cancer surgery.
After lung cancer surgery, many patients have reduced lung function, shortness of breath, lower exercise tolerance, and a risk of postoperative pulmonary complications. Standard care usually includes postoperative nursing, pain control, coughing and sputum clearance instruction, early mobilization, discharge education, and routine follow-up. However, patients often lack structured guidance, feedback, and monitoring after discharge.
Participants in this study will be randomly assigned to one of two groups. One group will use an intelligent pulmonary function exercise device for respiratory training during hospitalization and at home until 30 days after surgery. The prescribed training is two sessions per day, with each session including 30 expiratory training repetitions and 30 inspiratory training repetitions. The device records training completion and related training information and provides reminders and feedback. The other group will receive usual perioperative care, standard discharge education, and natural recovery follow-up without a study-specified respiratory training device or training prescription.
The main purpose of the study is to determine whether the intelligent pulmonary function exercise device improves recovery of forced expiratory volume in 1 second, or FEV1, from before surgery to 30 days after surgery. The study will also evaluate lung function at 90 days, symptoms, quality of life, walking capacity, training adherence, and postoperative complications.
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 不适用
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
1. Age 18 to 75 years. 2. Pathologically confirmed primary non-small cell lung cancer. 3. Scheduled to undergo elective thoracoscopic lobectomy or sublobar resection. 4. Able to understand the study and voluntarily sign written informed consent before surgery.
5. Able to communicate and complete study assessments and postoperative follow-up.
6. Able to use a smartphone independently or with assistance from a caregiver for training records.
7. Good lung re-expansion on postoperative chest imaging. 8. No chest tube drainage or no persistent air leak from chest tube drainage. 9. Clinical stage cT1-T2b, N0-N1, M0, stage IA-IIB. 10. Home environment allows safe training.
Exclusion Criteria:
1. Preoperative measured FEV1 less than 50% of predicted value. 2. Severe cardiopulmonary dysfunction or other conditions judged unsuitable for respiratory training.
3. Previous thoracic surgery or major thoracic trauma. 4. Significant cognitive impairment or psychiatric disorder that prevents cooperation with the study.
5. Pregnancy or breastfeeding. 6. Recent severe infection or active pulmonary disease.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:单组作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Intelligent Pulmonary Function Exercise Device Group
|
A digital pulmonary rehabilitation device used for active inspiratory and expiratory respiratory training.
The device records the number of completed training sessions, expiratory and inspiratory repetitions, training parameters, target completion, reminders, and interruptions.
Training data are synchronized to the study platform for adherence monitoring and remote follow-up.
|
|
有源比较器:Usual Care and Natural Recovery Group
|
Usual perioperative care includes standard postoperative nursing, analgesia, coughing and sputum clearance instruction, early mobilization, wound and drainage tube management, discharge education, and routine follow-up.
No structured pulmonary rehabilitation program assigned by the study team will be provided to the control group.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Change in Forced Expiratory Volume in 1 Second From Baseline to 30 Days After Surgery
大体时间:Baseline and 30 days after surgery
|
Baseline and 30 days after surgery
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Change in FEV1 From Baseline to 90 Days After Surgery
大体时间:Baseline and 90 days after surgery
|
Baseline and 90 days after surgery
|
|
Dyspnea-12 Score
大体时间:Baseline, postoperative day 1, before discharge, 1 week after surgery, and 30 days after surgery
|
Baseline, postoperative day 1, before discharge, 1 week after surgery, and 30 days after surgery
|
|
MD Anderson Symptom Inventory-Lung Cancer Module Score
大体时间:Baseline, 30 days after surgery, and 90 days after surgery
|
Baseline, 30 days after surgery, and 90 days after surgery
|
|
Six-Minute Walk Distance
大体时间:Baseline, 30 days after surgery, and 90 days after surgery
|
Baseline, 30 days after surgery, and 90 days after surgery
|
|
Postoperative Complications
大体时间:Up to 90 days after surgery
|
Up to 90 days after surgery
|
合作者和调查者
赞助
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.